GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo International PLC (LTS:0Y5F) » Definitions » Cyclically Adjusted PS Ratio

Endo International (LTS:0Y5F) Cyclically Adjusted PS Ratio : 0.00 (As of Jun. 21, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Endo International Cyclically Adjusted PS Ratio?

As of today (2024-06-21), Endo International's current share price is $0.0006. Endo International's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $317.40. Endo International's Cyclically Adjusted PS Ratio for today is 0.00.

The historical rank and industry rank for Endo International's Cyclically Adjusted PS Ratio or its related term are showing as below:

During the past years, Endo International's highest Cyclically Adjusted PS Ratio was 6.65. The lowest was 0.01. And the median was 0.53.

LTS:0Y5F's Cyclically Adjusted PS Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.06
* Ranked among companies with meaningful Cyclically Adjusted PS Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Endo International's adjusted revenue per share data for the three months ended in Dec. 2023 was $2.116. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $317.40 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Endo International Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Endo International's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo International Cyclically Adjusted PS Ratio Chart

Endo International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.43 0.22 - -

Endo International Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Endo International's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Endo International's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Endo International's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Endo International's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Endo International's Cyclically Adjusted PS Ratio falls into.



Endo International Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Endo International's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.0006/317.4
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Endo International's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Endo International's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.116/120.7486*120.7486
=2.116

Current CPI (Dec. 2023) = 120.7486.

Endo International Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 3.675 100.573 4.412
201406 3.629 100.773 4.348
201409 4.115 100.474 4.945
201412 4.163 99.576 5.048
201503 4.039 99.975 4.878
201506 3.967 100.573 4.763
201509 3.563 100.274 4.291
201512 4.790 99.676 5.803
201603 4.334 99.676 5.250
201606 4.132 101.072 4.936
201609 3.970 100.274 4.781
201612 5.571 99.676 6.749
201703 4.653 100.374 5.598
201706 3.924 100.673 4.707
201709 3.524 100.474 4.235
201712 3.442 100.075 4.153
201803 3.134 100.573 3.763
201806 3.193 101.072 3.815
201809 3.326 101.371 3.962
201812 3.505 100.773 4.200
201903 3.208 101.670 3.810
201906 3.093 102.168 3.656
201909 3.219 102.268 3.801
201912 3.372 102.068 3.989
202003 3.521 102.367 4.153
202006 2.942 101.769 3.491
202009 2.760 101.072 3.297
202012 3.242 101.072 3.873
202103 3.008 102.367 3.548
202106 3.059 103.364 3.573
202109 3.305 104.859 3.806
202112 3.378 106.653 3.824
202203 2.789 109.245 3.083
202206 2.421 112.779 2.592
202209 2.303 113.504 2.450
202212 2.363 115.436 2.472
202303 2.191 117.609 2.249
202306 2.325 119.662 2.346
202309 1.920 120.749 1.920
202312 2.116 120.749 2.116

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Endo International  (LTS:0Y5F) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Endo International Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Endo International's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Endo International (LTS:0Y5F) Business Description

Traded in Other Exchanges
N/A
Address
Simmonscourt Road, Ballsbridge, First Floor, Minerva House, Dublin, IRL, 4
Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. The company generates maximum revenue from the Branded Pharmaceuticals segment. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL.

Endo International (LTS:0Y5F) Headlines

No Headlines